Legal Representation
Attorney
Brick Power
USPTO Deadlines
Next Deadline
857 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220524)
Due Date
May 24, 2028
Grace Period Ends
November 24, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 25, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 24, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 8, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 8, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 16, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 2, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 1, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 18, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 25, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Medical devices, namely, portable light units for use in the fields of light therapy and light supplementation for neurological disorders; medical devices, namely, portable light units for use in the field of light therapy for neurological disorders; light boxes for providing light therapy for neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of neurological disorders; portable ocular light therapy apparatuses for the treatment of neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of motor-related neurological disorders; portable ocular light therapy apparatuses for the treatment of motor-related neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of Parkinson's disease; portable ocular light therapy apparatuses for the treatment of Parkinson's disease
First Use Anywhere:
20140700
First Use in Commerce:
20140700
Additional Information
Pseudo Mark
SPECTRA MAX
Classification
International Classes
010